Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

GeneproDX

GeneproDX
2013 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$13M LATEST DEAL AMOUNT
2 INVESTORS
Description

Researcher and developer of molecular diagnostic tests with the objective to eliminate thyroid cancer. The company specializes in the development of a multi-genetic test enabling doctors to eliminate high levels of imprecision in the detection of the disease, thereby effecting proper care on time.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Santiago
  • Chile
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore GeneproDX’s full profile, request a free trial.

GeneproDX Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 14-Dec-2017 $13M 0000 Completed Generating Revenue
1. Angel (individual) 31-Dec-2014 000 000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

GeneproDX Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Endurance Investments PE/Buyout Minority 000 0000 000000 0
Gust Angel Group Minority 000 0000 000000 0

GeneproDX Executive Team (2)

Name Title Board
Seat
Contact
Info
Hernán González Ph.D Founder, Chief Executive Officer and Co-Chief Operating Officer
Natalia Mena Ph.D Co-Chief Operating Officer